Sharp increase in the incidence and severity of invasive Streptococcus pyogenes infections in children after the COVID-19 pandemic (2019-2023): A nationwide multicenter study

Other authors

Institut Català de la Salut

[Cobo-Vázquez E] Department of Pediatrics, Hospital Universitario Fundación de Alcorcón, Alcorcón, Madrid, Spain. PhD Program in Medicine, Universidad Complutense de Madrid, Madrid, Spain. [Aguilera-Alonso D] Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. Centro de Investigación Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. [Grandioso-Vas D] Department of Microbiology, Hospital Universitario La Paz, Madrid, Spain. [Gamell A] Infectious Diseases Department, Hospital San Joan de Déu, Barcelona, Spain. [Rello-Saltor V] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Oltra-Benavent M] Department of Pediatrics, Hospital Universitario y Politécnico La Fe, Valencia, Spain. [Lung M] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-10-22T12:46:11Z

2025-10-22T12:46:11Z

2025-10



Abstract

Children; Group A streptococcus; Outbreak


Niños; Estreptococo del grupo A; Brote


Infants; Estreptococ del grup A; Brote


Objectives A global surge in pediatric invasive group A streptococcal infection (iGAS) was reported after autumn 2022. This study analyzed the epidemiology and severity of iGAS in Spain, comparing two periods; P1: pre-outbreak (January 2019-September 2022) versus P2: outbreak (October 2022-July 2023). Methods Children ≤16 years with iGAS enrolled in the Spanish PedGAS-net (2019-2023), were included. Bacterial isolates were analyzed for emm typing, antibiotic susceptibility, and whole genome sequencing. Multivariate analysis identified risk factors for PICU admission and mortality. Results 558 cases were included; 307 (55.1%) were male, with a median age of 43.9 months (IQR:19.3-84.1). There were significantly more iGAS in P2 (35.7 vs. 4.5 cases/month, P < 0.001), with higher PICU admissions (51.3% vs. 30.8%, P < 0.001). Pneumonia was the most common syndrome (32.3%), with pleural effusion in 58.3%. Of the 130 samples available for emm-typing, the most frequent were emm1 (56.1%) and emm12 (27.1%). 245 (43.9%) required PICU admission. Factors associated with PICU were streptococcal toxic shock syndrome (STSS), pneumonia, necrotizing fasciitis, acute kidney failure, and previous consultation before diagnosis. The emm1 (especially M1UK) increased PICU risk. 11 children (2.0%) died. STSS, sepsis, and central nervous system infection were associated with mortality. Conclusion In Spain, pediatric iGAS cases sharply increased during 2022-2023, with a remarkable increase in severity. Epidemiological surveillance of iGAS remains crucial.


This work was partially funded by the Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC: IM23/INFEC/3).

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

International Journal of Infectious Diseases;159

https://doi.org/10.1016/j.ijid.2025.107982

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)